Rui Baptista Gonçalves

Rui Baptista Gonçalves

Auto-generated profile, based on publicly available information

Rui Baptista Gonçalves

Dermatology Department, Northern Care Alliance, Salford Royal NHS Foundation Trust , Salford

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAna Paula Silva
Ana Paula Silva
FMFilipa Mendes
Filipa Mendes
ECEduarda Carias
Eduarda Carias
RGRui Baptista Gonçalves
Rui Baptista Gonçalves
AFAndré Fragoso
André Fragoso
EAEdgar De Almeida
Edgar De Almeida
Background: Research over the past decade has focused on the role of Klotho as a cardio protective agent that prevents the effects of aging on the heart and reduces the burden of cardiovascular disease CVD. The role of the interaction between fibroblast growth factor 23-(FGF-23)/Klotho in Klotho-mediated actions is still under debate. The main objective was to ascertain the potential use of plasmatic Klotho and FGF23 as markers for CKD-associated cardiac disease and mortality. Methods: This was a prospective analysis conducted in an outpatient diabetic nephropathy clinic, enrolling 107 diabetic patients with stage 2–3 CKD. Patients were divided into three groups according to their left ventricular mass index and relative wall thickness. Results: Multinomial regression analysis demonstrated that low Klotho and higher FGF-23 levels were linked to a greater risk of concentric hypertrophy. In the generalized linear model (GLM), Klotho, FGF-23 and cardiac geometry groups were statistically significant as independent variables of cardiovascular hospitalization (p = 0.007). According to the Cox regression model, fatal cardiovascular events were associated with the following cardiac geometric classifications; eccentric hypertrophy (p = 0.050); concentric hypertrophy (p = 0.041), and serum phosphate ≥ 3.6 mg/dL (p = 0.025), FGF-23 ≥ 168 (p = 0.0149), α-klotho < 313 (p = 0.044). Conclusions: In our population, Klotho and FGF23 are associated with cardiovascular risk in the early stages of CKD.

26 April 2023 in JEADV Clinical Practice
Verified
Journal Article
Open access
ADAoife U. Daly
Aoife U. Daly
RGRui Baptista Gonçalves
Rui Baptista Gonçalves
ELEva Lau
Eva Lau
JBJoanne Bowers
Joanne Bowers
NHNaayema Hussaini
Naayema Hussaini
ALAlison M. Layton
Alison M. Layton
How does low‐dose oral isotretinoin compare with recommended and high‐dose oral isotretinoin in terms of efficacy, adverse effect profile, duration of remission, economic profile and rate and severity of relapse? A systematic literature search of EMBASE, MEDLINE, PubMed and The Cochrane Library from 1983 to July 2022 was conducted to identify randomised control trials (RCTs), cohort studies and cross‐sectional studies investigating the treatment of acne vulgaris with oral isotretinoin. This systematic review of the literature sought to explore and compare the use of different isotretinoin dosing regimens. Primary outcomes were efficacy, relapse, and safety profiles of oral isotretinoin of varying doses. Secondary outcomes included adverse events and economic considerations. The quality of studies, including risk of bias was assessed using GRADE (Grading of Recommendations, Assessment, Development and Evaluations). A total of 32 studies were included. Severe acne responds better to conventional or high fixed daily doses of isotretinoin. In cases of mild to moderate acne, where oral isotretinoin was prescribed, clearance rates were comparable with low, conventional or high dosage regimens. Despite this, relapse was more frequent in those treated with a lower dose. The severity of mucocutaneous adverse effects worsens as the dose of isotretinoin is increased. Comparison between studies was challenging due to differing methods of assessment, outcome measures and duration of follow‐up. This review highlights the need for an adequately powered RCT comparing low, conventional and high doses of oral isotretinoin to establish optimal dosing for treatment and prevention of relapse in acne vulgaris.

4 July 2017 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
ASAna Paula Silva
Ana Paula Silva
FMFilipa Mendes
Filipa Mendes
LPLuísa Pereira
Luísa Pereira
AFAndré Fragoso
André Fragoso
RGRui Baptista Gonçalves
Rui Baptista Gonçalves
`N`Pedro Leao Neves
`Pedro Leao Neves

10 November 2023 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
HCHugo Costa
Hugo Costa
HVHugo Vinhas
Hugo Vinhas
RCRita Calé
Rita Calé
EPErnesto Pereira
Ernesto Pereira
JSJesusDaniel Santos
JesusDaniel Santos
EOEduardo Infante de Oliveira
Eduardo Infante de Oliveira
Concerns surrounding the consequences of ionizing radiation (IR) have increased among interventional cardiology (IC). Despite this, the ever-growing complexity of diseases as well as procedures can lead to greater exposure to radiation. The aim of this survey, led by Portuguese Association of Interventional Cardiology (APIC), was to evaluate the level of awareness and current practices on IR protection among its members. An online survey was emailed to all APIC members, between August and November 2021. The questionnaire consisted of 50 questions focusing on knowledge and measures of IR protection in the catheterization laboratory. Results were analyzed using descriptive statistics. From a response rate of 46.9%, the study obtained a total sample of 159 responses (156 selected for analysis). Most survey respondents (66.0%) were unaware of the radiation exposure category, and only 60.4% reported systematically using a dosimeter. A large majority (90.4%) employed techniques to minimize exposure to radiation. All participants used personal protective equipment, despite eyewear protection only being used frequently by 49.2% of main operators. Ceiling suspended shields and table protectors were often used. Only two-thirds were familiar with the legally established limit on radiation doses for workers or the dose that should trigger patient follow-up. Most of the survey respondents had a non-certified training in IR procedures and only 32.0% had attended their yearly occupational health consultation. Safety methods and protective equipment are largely adopted among interventional cardiologists, who have shown some IR awareness. Despite this, there is room for improvement, especially concerning the use of eyewear protection, monitoring, and certification.

20 November 2018 in HIV & AIDS Review
Verified
Journal Article
Open access
PDF file
RBRui Baptista-Gonçalves
Rui Baptista-Gonçalves
AMAna Marreiros
Ana Marreiros
GAGonçalo Figueiredo Augusto
Gonçalo Figueiredo Augusto
Introduction Evidence shows that pre-exposure prophylaxis (PrEP) is highly effective in preventing sexually acquired human immunodeficiency virus (HIV) infection. Whilst its implementation is limited to the US and some countries where demonstration projects have taken place, PrEP has recently...

21 December 2023 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
HCHugo Costa
Hugo Costa
MEMiguel Espírito-Santo
Miguel Espírito-Santo
JBJoão Bispo
João Bispo
JGJoão Guedes
João Guedes
JMJorge Mimoso
Jorge Mimoso
HVHugo Vinhas
Hugo Vinhas
Coronary chronic total occlusions (CTOs) are relatively common findings in patients with type 2 diabetes mellitus (T2DM). However, the indication for percutaneous coronary intervention (PCI) and its clinical benefit in these patients remain controversial. A single-center retrospective cohort study with prospectively collected outcomes was carried out with CTO patients undergoing PCI in 2019 and 2020. Patients were divided into two groups according to previous T2DM diagnosis (T2DM and non-T2DM). The primary outcome was recurrence of angina and/or heart failure symptoms and secondary outcomes were myocardial infarction and all-cause mortality. A total of 177 patients (82.5% male) were included in the analysis, with a mean age of 65±11 years. The primary outcome (total symptom recurrence) occurred in 16.6% of the sample, with no difference between groups (non-T2DM 13.6% vs. T2DM 21.2%, p=0.194) in a two-year follow-up. Angina recurrence was significantly more frequent in T2DM patients (15.2%, p=0.043). The presence of T2DM was not an independent predictor of symptom recurrence (p=0.429, HR 1.37, 95% CI 0.62-2.98). Myocardial infarction and all-cause mortality were also not different between groups (T2DM 1.5%, p=0.786 and 4.5%, p=0.352, respectively, on survival analysis). Independent predictors of all-cause mortality were left ventricular function and creatine clearance (p=0.039, HR 0.92, 95% CI 0.85-0.99 and p=0.013, HR 0.96, 95% CI 0.93-0.99, respectively). T2DM did not influence outcomes in CTO patients undergoing PCI, and its presence should not be a limiting factor in deciding on CTO revascularization.